Abstract
The Masculinity in Chronic Disease Inventory (MCD-I) is a new measure of internalized masculine beliefs previously validated in the context of prostate cancer. The present study assessed the validity of the MCD-I in men with other chronic diseases to explore its potential for wider application. A cross-sectional survey of 633 men aged 47–93 years old (
Approaches to the measurement of masculinity encompass a range from the proposing prescriptive and proscriptive social norms that are distinct from gender identity (Thompson, Pleck, & Ferrera, 1992) to a normative perspective where cultural traditions and social practices are seen as shaping and shaped by socially constructed masculinities and gender ideals (Connell & Messerschmidt, 2005). Extending this narrative, Thompson and Bennett (2015) suggested that once internalized, these gender ideals become individualized belief systems about masculinity, that is masculine beliefs. The importance for men’s health, then, is that these belief systems may help or hinder men’s health-promoting practices, wherein accurately mapping men’s health and illness behaviors with valid and responsive measurement is crucial (Luyt, 2015).
In terms of health, chronic disease in particular is known to be associated with masculinity, wherein societal constructions of masculinity can hinder health behaviors but in turn, chronic disease can impinge negatively on personal perceptions of masculinity (Zanchetta et al., 2017). Until the work of Chambers et al. (2016), who developed the Masculinity in Chronic Disease Inventory (MCD-I), no validated measures existed that tapped into internalized masculine beliefs applicable to researching chronic diseases. Importantly, the MCD-I was derived from a specific qualitative examination of men’s self-reported experiences of prostate cancer, thereby ensuring the items and constructs within the scale were relevant to the health, cultural, and social context of these men. Emergent scale domains included Strength, Sexual Importance/Priority, Emotional Self-Reliance, Optimistic Capacity, Family Responsibilities and Action Approach. Further, these domains fit well within the theoretical lens of socially constructed masculinities. In this germinal study, the MCD-I demonstrated good convergent, divergent, and discriminant validity, with excellent reliabilities.
However, as this instrument was developed and tested with a population of men who had been diagnosed with prostate cancer, it is important to broaden the scope of the measure to access conceptions of masculinity that are not tied to a single diagnostic group. For example, Chan and Corvin (2016) conducted a qualitative investigation finding links between masculinity, depression, and chronic diseases such as cardiovascular disease, diabetes, and hypertension, finding a complex interplay of contextual factors. Of particular interest in a broader chronic disease population is the role of sexual identity in masculinity. Sexual Importance/Priority emerged as a separate factor in the sample of Chambers et al. (2016), and this is consonant with the elevated potential for erectile dysfunction in prostate cancer treatment. Yet sexual difficulties and in particular erectile dysfunction are associated with a variety of chronic conditions in men (e.g., Sutsunbuloglu and Vural, 2018). Many different factors have been shown to affect men’s conceptions of erectile dysfunction and also the role of sexual difficulties in constraining, or not, conceptions of masculinity (Thompson and Barnes, 2013; Wentzell, 2014). It is necessary to examine both the nature of sexual importance and its association with erectile dysfunction in contexts beyond that of prostate cancer.
Accordingly, to further assess the utility of the MCD-I, the present study addresses the validity of the instrument in a large sample of men with a wide range of chronic diseases. Although it could be expected that a similar factor structure would emerge as for the original prostate sample, the present study included both exploratory and confirmatory analyses to allow the most appropriate structure for the broader population. With this approach, the MCD-I items were not constrained to the structure determined by previous empirical analyses but rather the factor structure was determined directly by initial analyses with the present population. Validation techniques were included to mitigate against overfitting and sample-specific associations. In view of the centrality of erectile dysfunction, the ability of the instrument to discriminate with respect to this variable was assessed.
Method
Participants and Procedure
Data for the present study were drawn from the Florey Adelaide Male Ageing Study (FAMAS), a prospective cohort of randomly-selected, community-dwelling middle-aged to elderly men, extensively characterized, including information on chronic disease status. Details of the broader study are reported elsewhere (Martin, Haren, Middleton, & Wittert, 2007). Written informed consent was obtained by all participants. Ethical approval for the study was obtained from the Royal Adelaide Hospital Research Ethics committee and, where appropriate, the Aboriginal Health Research Ethics Committee of South Australia (protocol number 020305). The project is currently funded by NHMRC project grants (#1122342; #627227), with previous funding from the South Australian Premier’s Science and Research Fund and The University of Adelaide’s Florey Foundation. Data collected through the 2015 annual follow-up survey for 633 men were utilized (response rate: 68.7% of eligible participants).
Measures
MCD-I
The 22-item MCD-I was administered to all participants. Participants indicated on a 5-point Likert type scale how true each of the statements were for them, from 1 =
Erectile function
Erectile function was measured with a single self-report item: “Impotence means being unable to get and keep an erection that is rigid enough for satisfactory sexual activity. How would you describe yourself?” Participants answered on a scale of 1 to 5, from 1 =
Covariate data
Men reported their age, relationship and family status, sexuality, education, employment status, and presence of chronic disease. Chronic disease status was collected as the patient’s recall of having ever been diagnosed by a physician (i.e., Have you ever been told by a doctor that you have any of the following conditions?) with any of the conditions presented in a list. Body mass index (BMI) was collected through a previous clinic visit.
Statistical Analysis
The structure of the MCDI was examined using a two-part strategy. As the model was to be assessed in a new population to that in which it was developed, the sample was split randomly into two equal subsamples. Model development was conducted on one subsample and then assessed via confirmatory techniques in the other. First, exploratory factor analysis (EFA) via a minimum residual approach with promax rotation was used to examine the possible factor structure in one half of the sample. The potential number of factors was examined with Velicer’s Minimum Average Partial (MAP; Velicer, 1976). Second, confirmatory factor analysis (CFA) was used to test the fit of the suggested covariance structure in the second, holdout sample. Estimation was by robust maximum likelihood in order to reduce the effects of the severe skew present in the data. As recommended by contemporary methodologists (Hu & Bentler, 1999; Kline, 2015), fit was assessed with the robust variants of chi-square, root mean square error of approximation (RMSEA), comparative fit index (CFI), and standardized root mean square residual (SRMR). EFA was conducted using tools in the psych package (Revelle, 2018) and CFA analyses were conducted using the lavaan package (Rosseel, 2012).
Internal consistency reliability for each scale was assessed with Cronbach’s α. Discriminant validity was assessed using Pearson’s
Results
Participants
Participants ages ranged from 47 to 93 years old (
Sociodemographic Characteristics of Participants (
Medical Characteristics of Participants (
Exploratory Factor Analysis
Inspection of the MAP plots suggested that between four and five factors may have been present in the data. Although these were fewer than the six factors observed by Chambers et al. (2016), both solutions were examined further. The five-factor solution (see Table 3) accounted for 57% of the variance. The factors were named Optimistic Action, Sexual Importance/Priority, Family Responsibilities, Emotional Self-Reliance, and Strength/Fitness. The five-factor solution was identical to the four-factor solution except for the Strength/Fitness factor that was composed of three items that were the only ones that did not load on any factors in the four-factor solution. This solution is similar to that reported by Chambers et al. (2016) in that the Sexual Importance/Priority, Family Responsibilities, and Emotional Self-Reliance factors are composed of the same items in each analysis, and Strength/Fitness included three of the items from the previous Strength factor. The novel Optimistic Action factor was composed of highest loading items such as: “I am a positive person” (item 12); “I have a forward thinking mind-set” (item 16); and “My approach is to get on with things” (item 21). As presented in Table 3, the items on this factor consist equally of items indicating both an optimistic stance and an orientation towards action. The five factors were correlated with each other but not excessively so, with correlations ranging from 0.1 to 0.53 (see Table 4).
Five-Factor Solution for MCD-I EFA (
Correlations Between MCD-I Subscales and Total Scale (
Confirmatory Factor Analysis
The five-factor model was submitted to a CFA on the responses of the 311 men in the second, holdout subsample. Initial inspection of fit indices suggested the model did not fit according to conventional criteria (Hu & Bentler, 1999; Kline, 2015).
Discriminant Validity
Correlation analysis showed that the five-factor model discriminated between men on the basis of erectile dysfunction and age. Optimistic Action (
Discussion
The present study demonstrates the efficacy and relevance of the MCD-I as an important measure of masculinity for men with chronic disease. The close similarity between the factor structure identified in this study compared to that reported previously by Chambers et al. (2016) shows how sexual well-being, family relationships, physical strength and activity, and an active and optimistic approach to life appear central to masculine identity for men experiencing chronic disease. From this, it can be concluded that this measure is suitable for wider application applying the revised five-factor model. In line with recommendations by Thompson and Bennett (2015), the MCD-I offers a validated tool by which to collect empirical evidence about the connections between masculinities and chronic disease. As Oliffe et al. (2019) affirmed, consistent use of validated end-user informed masculinity measures is key to bridging qualitative and quantitative approaches as well as transitioning descriptive study findings to inform the design and formal evaluation of gender-sensitized men’s interventions and services. Further, in light of men’s increasing life expectancy in Western countries, and the likelihood of men’s chronic disease rates growing in step with this trend, there is an ever-pressing need to describe and attend to the gendered dimensions of men’s illness (and health).
Limitations of this research include the cross-sectional study design; however the diverse participant population in terms of chronic disease is a strength. There remains a need to examine and compare the measurement of masculinity in young men who experience chronic disease (i.e., hemophilia, Crohn’s, epilepsy) as well as sexual minority men (i.e., gay, bisexual) to gain clarity around what aspects of masculinity intersect with chronic disease in these subgroups. In addition, an important area of future research is to examine how masculinity, as measured by the MCD-I, relates to health outcomes and health-promoting practices as a means to informing the design and evaluation of gender-sensitized interventions targeting men in the context of chronic disease. For example, an instrument such as the MCD-I that assesses masculinity as a multidimensional construct can allow researchers to assess the role of masculinity in moderating the effectiveness of interventions with men a priori and on a sound theoretical basis, rather than addressing post-hoc justifications for unexpected results. This would be consistent with the work of Thompson and Barnes (2013) who reported marked differences in conceptions of sexual performance between men with and without erectile dysfunction. In addition, a clearer understanding of masculinity scores could aid in targeting important health messages, such as those endorsing self-care behaviors, to men with chronic illness. Men reporting high Emotional Self-Reliance and men reporting high Family Responsibilities scores might respond more positively to differently framed persuasive health messages.
In conclusion, the MCD-I is a valid measure of internalized masculine beliefs for men with chronic disease that is sensitive to age and to sexual health. The tailoring of health services for men in connection to these masculine beliefs is a priority.
Footnotes
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research described in this article received support from NHMRC project grant #627227 to Gary Wittert.
